Literature DB >> 7485134

A randomized, placebo-controlled, multicenter trial evaluating alternate-day prednisone and fish oil supplements in young patients with immunoglobulin A nephropathy. Scientific Planning Committee of the IgA Nephropathy Study.

R J Hogg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7485134     DOI： 10.1016/0272-6386(95)90445-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  9 in total

Review 1.  Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; A Boldt; U Sack; J Fahnert
Journal:  Clin Exp Immunol       Date:  2016-09-08       Impact factor: 4.330

2.  Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations.

Authors:  Angela M Zivkovic; Jun Yang; Katrin Georgi; Christine Hegedus; Malin L Nording; Aifric O'Sullivan; J Bruce German; Ronald J Hogg; Robert H Weiss; Curt Bay; Bruce D Hammock
Journal:  Metabolomics       Date:  2012-12       Impact factor: 4.290

Review 3.  Omega 3 fatty acids for prevention and treatment of cardiovascular disease.

Authors:  L Hooper; R L Thompson; R A Harrison; C D Summerbell; H Moore; H V Worthington; P N Durrington; A R Ness; N E Capps; G Davey Smith; R A Riemersma; S B J Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

4.  Effects of fish oil during hemodialysis on nutritional status and quality of life: a randomized double-blinded trial.

Authors:  Chi Zhang; Chang Ge; Junsheng Wang; Dong Sun
Journal:  Food Nutr Res       Date:  2020-08-03       Impact factor: 3.894

5.  Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

Authors:  Asmaa S Abdelhamid; Tracey J Brown; Julii S Brainard; Priti Biswas; Gabrielle C Thorpe; Helen J Moore; Katherine Ho Deane; Fai K AlAbdulghafoor; Carolyn D Summerbell; Helen V Worthington; Fujian Song; Lee Hooper
Journal:  Cochrane Database Syst Rev       Date:  2018-11-30

Review 6.  Omega-3 fatty acid supplementation as an adjunctive therapy in the treatment of chronic kidney disease: a meta-analysis.

Authors:  Jing Hu; Zuoliang Liu; Hao Zhang
Journal:  Clinics (Sao Paulo)       Date:  2017-01-01       Impact factor: 2.365

7.  Quantitative Comparison of the Clinical Efficacy of 6 Classes Drugs for IgA Nephropathy: A Model-Based Meta-Analysis of Drugs for Clinical Treatments.

Authors:  Jiesen Yu; Jieren Luo; Haoxiang Zhu; Zichao Sui; Hongxia Liu; Lujin Li; Qingshan Zheng
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

Review 8.  Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

Authors:  Asmaa S Abdelhamid; Tracey J Brown; Julii S Brainard; Priti Biswas; Gabrielle C Thorpe; Helen J Moore; Katherine Ho Deane; Fai K AlAbdulghafoor; Carolyn D Summerbell; Helen V Worthington; Fujian Song; Lee Hooper
Journal:  Cochrane Database Syst Rev       Date:  2018-07-18

9.  A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616].

Authors:  Ronald J Hogg; Robert J Wyatt
Journal:  BMC Nephrol       Date:  2004-03-25       Impact factor: 2.388
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.